Gastrointestinal dysmotility in rodent models of Parkinson's disease

被引:1
|
作者
Pellegrini, Carolina [1 ]
Travagli, R. Alberto [2 ]
机构
[1] Univ Pisa, Dept Clin & Expt Med, Unit Histol & Med Embryol, Pisa, Italy
[2] Neurobiol Res, Newport, NC USA
关键词
animal models; enteric nervous system; gastrointestinal symptoms; gut microbiota; Parkinson's disease; ENTERIC DOPAMINERGIC-NEURONS; 6-HYDROXYDOPAMINE RAT MODEL; DETECT LEWY PATHOLOGY; NIGRA PARS COMPACTA; MPTP MOUSE MODEL; ALPHA-SYNUCLEIN; GASTRIC DYSMOTILITY; INTESTINAL MOTILITY; NERVOUS-SYSTEM; VAGAL PATHWAY;
D O I
10.1152/ajpgi.00225.2023
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Multiple studies describe prodromal, nonmotor dysfunctions that affect the quality of life of patients who subsequently develop Parkinson's disease (PD). These prodromal dysfunctions comprise a wide array of autonomic issues, including severe gastrointestinal (GI) motility disorders such as dysphagia, delayed gastric emptying, and chronic constipation. Indeed, strong evidence from studies in humans and animal models suggests that the GI tract and its neural, mainly vagal, connection to the central nervous system (CNS) could have a major role in the etiology of PD. In fact, misfolded alpha-synuclein aggregates that form Lewy bodies and neurites, i.e., the histological hallmarks of PD, are detected in the enteric nervous system (ENS) before clinical diagnosis of PD. The aim of the present review is to provide novel insights into the pathogenesis of GI dysmotility in PD, focusing our attention on functional, neurochemical, and molecular alterations in animal models.
引用
收藏
页码:G345 / G359
页数:15
相关论文
共 50 条
  • [1] Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease
    Tian, Y. -M.
    Chen, X.
    Luo, D. -Z.
    Zhang, X. -H.
    Xue, H.
    Zheng, L. -F.
    Yang, N.
    Wang, X. -M.
    Zhu, J. -X.
    [J]. NEUROSCIENCE, 2008, 153 (03) : 634 - 644
  • [2] Transgenic rodent models of Parkinson's disease
    Harvey, B. K.
    Wang, Y.
    Hoffer, B. J.
    [J]. RECONSTRUCTIVE NEUROSURGERY, 2008, 101 : 89 - 92
  • [3] Promising rodent models in Parkinson's disease
    Imbriani, Paola
    Sciamanna, Giuseppe
    Santoro, Massimo
    Schirinzi, Tommaso
    Pisani, Antonio
    [J]. PARKINSONISM & RELATED DISORDERS, 2018, 46 : S10 - S14
  • [4] Parkinson’s disease: a rethink of rodent models
    Heather L. Melrose
    Sarah J. Lincoln
    Glenn M. Tyndall
    Matthew J. Farrer
    [J]. Experimental Brain Research, 2006, 173 : 196 - 204
  • [5] Parkinson's disease: a rethink of rodent models
    Melrose, Heather L.
    Lincoln, Sarah J.
    Tyndall, Glenn M.
    Farrer, Matthew J.
    [J]. EXPERIMENTAL BRAIN RESEARCH, 2006, 173 (02) : 196 - 204
  • [6] Are rodent models of Parkinson's disease behaving as they should?
    Vingill, Siv
    Connor-Robson, Natalie
    Wade-Martins, Richard
    [J]. BEHAVIOURAL BRAIN RESEARCH, 2018, 352 : 133 - 141
  • [7] Sleep Disorders in Rodent Models of Parkinson's Disease
    Medeiros, Daniel de Castro
    Aguiar, Cleiton Lopes
    Dutra Moraes, Marcio Flavio
    Fisone, Gilberto
    [J]. FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [8] Parkinson's disease rodent models: Are they suitable for DBS research?
    Merino Ruiz, Miguel Cesar
    Guimaraes, Rayanne Poletti
    Mortari, Marcia Renata
    [J]. JOURNAL OF NEUROSCIENCE METHODS, 2022, 380
  • [9] Sensory neuropathy and nociception in rodent models of Parkinson's disease
    Valek, Lucie
    Auburger, Georg
    Tegeder, Irmgard
    [J]. DISEASE MODELS & MECHANISMS, 2019, 12 (06)
  • [10] Rodent models of Parkinson's disease: beyond the motor symptomatology
    Campos, Filipa L.
    Carvalho, Miguel M.
    Cristovao, Ana C.
    Je, Goun
    Baltazar, Graca
    Salgado, Antonio J.
    Kim, Yoon-Seong
    Sousa, Nuno
    [J]. FRONTIERS IN BEHAVIORAL NEUROSCIENCE, 2013, 7